Nasdaq

Vertex Appoints Carmen Bozic, M.D., as New Chief Medical Officer and Nia Tatsis, Ph.D., as New Chief Regulatory Officer

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Carmen Bozic, M.D., has been appointed as the company’s Executive Vice President, Global Medicines ...
FierceBiotech

Vertex Announces Appointment of Jeffrey A. Chodakewitz, M.D., as Chief Medical Officer and Senior Vice President of Global Medicines Development

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced the appointment of Jeffrey A. Chodakewitz, M.D., as Chief Medical Officer and Senior Vice President. Dr. Chodakewitz has more than 20 ...
Yahoo Finance

Vertex to Participate in Upcoming March Investor Conferences

BOSTON, February 18, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in three upcoming investor conferences. Stuart Arbuckle, ...
Investing

Vertex Pharmaceuticals executive vice president sells over $2 million in company stock

Vertex Pharmaceuticals (NASDAQ:VRTX) Incorporated's (NASDAQ:VRTX) Executive Vice President and Chief Regulatory & Quality Officer, Ourania Tatsis, has sold a significant number of shares in the ...
Stockhouse

Ophthotech Announces Election of Ian F. Smith, Vertex Executive Vice President and Chief Financial Officer, to Its Board of Directors

Ophthotech Announces Election of Ian F. Smith, Vertex Executive Vice President and Chief Financial Officer, to Its Board of Directors Ophthotech Corporation (Nasdaq:OPHT) today announced the election ...
FierceBiotech

Vertex Pharmaceuticals Incorporated (VRTX) Announces Appointment Of Jeffrey A. Chodakewitz, M.D., As Chief Medical Officer And Senior Vice President Of Global Medicines Development

BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced the appointment of Jeffrey A. Chodakewitz, M.D., as Chief Medical Officer and Senior Vice President. Dr.